RSLS (ReShape Lifesciences Inc) Company Projected Revenue
ReShape Lifesciences (RSLS) efficiency relies on the popularity of Lap-Band systems and FDA approval. The company's projected sales metric in daily price action on the GURU.Markets chart is 0.01. Cost optimization is achieved through contract electronics assembly, while growth is driven by recruiting leading innovative engineers in the field of obesity treatment.
Analytical breakdowns and data insights for company ReShape Lifesciences Inc (RSLS)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital ReShape Lifesciences|RSLS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital ReShape Lifesciences|RSLS - Company Total Debt|Debts to Book Capitalization ReShape Lifesciences, Inc.|RSLS - Company Long-Term Debts|Company Short-Term Debt ReShape Lifesciences|Quick Liquidity Indicator reshapelifesciences.com
- earnings and market ratios statistics:
RSLS - Final Profit|Projected Future Earnings ReShape Lifesciences|RSLS - Market Cap to Earnings|Future Price to Earnings ReShape Lifesciences|RSLS - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio ReShape Lifesciences, Inc.|RSLS - Operating profit EBITDA|Net earnings per share (EPS TTM) ReShape Lifesciences|RSLS - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months reshapelifesciences.com|RSLS - Earnings per share trend in current year|Net earnings per share growth forecast for next year ReShape Lifesciences
- sales and revenue data:
Fundamental company analysis:ReShape Lifesciences Inc.
ReShape Lifesciences (RSLS) business is heavily dependent on the bariatric surgery segment, which creates risks due to the expansion of new weight-loss drugs. The f_sales_co calculation model estimates future cash flows based on market share expansion rates. The organization's current projected sales volume is fixed at 0.01. The dynamics of this indicator demonstrate the actual scale of product commercialization. A sharp increase in the curve may signal a revaluation of the cost of capital.
Analysis of competing companies
Company Future Sales Volume DXCM (DexCom, Inc.)|PEN (penumbrainc.com) - Company Future Revenue|Company Projected Revenue Novanta NOVT|HAE - Company Future Sales Volume|Inspire Sleep - Projected Sales Volume|Company Expected Sales Volume Procept|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode) - Projected Sales Volume|Picard Medical Corp (PMI) - Company Future Sales|Projected Sales Volume SRDX|Company Future Sales Volume Eversense SENS|Projected Sales Volume NPCE (NeuroPace, Inc.)|Projected Sales Volume Tactile Systems Technology, Inc. TCMD|SNWV - Company Projected Revenue|OM: Company Projected Revenue|ELMD (smartvest.com) - Company Future Sales Volume|LENSAR Inc - Company Future Revenue|RCEL (AVITA Medical, Inc.) - Projected Sales Volume|Company Expected Sales Volume Profound Medical Corporation PROF|Company Projected Revenue Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Company Sales Forecast|Apyx Medical Corporation - Company Future Sales Volume|Projected Sales Volume IceCure Medical Ltd. ICCM|Pulmonx Corp. - Projected Sales Volume|Company Future Sales TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Company Projected Revenue|Company Expected Revenue SRTS (Sensus Healthcare Inc)|Company Projected Revenue Zynex Inc|Company Future Sales Volume electroCore Medical (ECOR)|Projected Sales Volume RBOT|IINN - Company Expected Sales Volume|Company Projected Revenue SeaStar Medical ICU|IRIX: Company Revenue Forecast|INBS: Company Future Sales Volume|Beyond Air, Inc. - Company Projected Revenue Volume|Profusa Inc (PFSA) - Company Projected Revenue|STRATA Skin Sciences, Inc. - Company Future Revenue|GCTK (GlucoTrack, Inc.) - Projected Sales Volume|Company Expected Sales Volume nanovibronix.com NAOV|Company Projected Revenue Venus Concept Corp (VERO)|Company Future Sales Nuwellis Corp|Projected Sales Volume AEMD (Aethlon Medical)|Company Future Revenue ASXC|Avinger - Projected Sales Volume|BSGM - Projected Sales Volume|Cutera, Inc (CUTR) - Company Projected Revenue|Company Expected Revenue KNW (Know Labs Corporation)|NARI (Inari Medical, Inc.) - Projected Sales Volume|Company Expected Sales Volume nevro.com NVRO|Company Future Sales Volume SILK (Silk Road Medical)
